|
|
|
Volumn 31, Issue 185, 1997, Pages 4-46
|
|
Prognostic factors in prostate cancer
a
|
|
Author keywords
Apoptosis; bcl 2; Biopsy; Castration therapy; Immunohistochemistry; Ki 67 antigen; p53 protein; Prognosis; Prostatic neoplasms; Radiation; Survival
|
|
Indexed keywords
KI 67 ANTIGEN;
PROSTATE SPECIFIC ANTIGEN;
PROTEIN BCL 2;
PROTEIN P53;
TUMOR MARKER;
ADULT;
ANTIGEN DETECTION;
ARTICLE;
CANCER DIAGNOSIS;
CANCER EPIDEMIOLOGY;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CARCINOGENESIS;
CASTRATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MICTURITION DISORDER;
PRIORITY JOURNAL;
PROGNOSIS;
PROSTATE CANCER;
STATISTICAL ANALYSIS;
TREATMENT OUTCOME;
AGED;
CANCER STAGING;
CELL DIVISION;
ENZYME IMMUNOASSAY;
FOLLOW UP;
MIDDLE AGED;
MORTALITY;
PATHOLOGY;
PHYSIOLOGY;
PROSTATE;
PROSTATE TUMOR;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
ADULT;
AGED;
AGED, 80 AND OVER;
CELL DIVISION;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOENZYME TECHNIQUES;
KI-67 ANTIGEN;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PROGNOSIS;
PROSTATE;
PROSTATIC NEOPLASMS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
TUMOR SUPPRESSOR PROTEIN P53;
|
|
EID: 0030631774
PISSN: 03008886
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (23)
|
|
References (200)
|
